Fresenius SE & Co. KGaA Share Price

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Real-time Estimate Tradegate 03:06:30 13/05/2024 pm IST 5-day change 1st Jan Change
28.54 EUR -0.47% Intraday chart for Fresenius SE & Co. KGaA +2.08% +1.64%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 22.7B 24.48B 2,044B Sales 2025 * 23.8B 25.67B 2,143B Capitalization 16.15B 17.42B 1,454B
Net income 2024 * 1.39B 1.5B 125B Net income 2025 * 1.78B 1.92B 160B EV / Sales 2024 * 1.37 x
Net Debt 2024 * 15B 16.17B 1,350B Net Debt 2025 * 13.24B 14.28B 1,192B EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
11.6 x
P/E ratio 2025 *
9.01 x
Employees 1,90,863
Yield 2024 *
3.34%
Yield 2025 *
3.68%
Free-Float 73.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.51%
1 week+2.08%
Current month+2.00%
1 month+12.63%
3 months+10.84%
6 months+13.94%
Current year+1.64%
More quotes
1 week
27.42
Extreme 27.42
29.55
1 month
25.17
Extreme 25.17
29.55
Current year
24.32
Extreme 24.32
29.55
1 year
23.93
Extreme 23.93
31.22
3 years
19.69
Extreme 19.69
47.60
5 years
19.69
Extreme 19.69
51.54
10 years
19.69
Extreme 19.69
80.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 12/21/12
Director of Finance/CFO 44 01/19/01
Compliance Officer - 18/23/18
Members of the board TitleAgeSince
Director/Board Member 69 20/15/20
Chairman 69 01/20/01
Director/Board Member 63 13/16/13
More insiders
Date Price Change Volume
13/24/13 28.52 -0.52% 207 894
10/24/10 28.67 +2.28% 1,494,712
09/24/09 28.03 -1.58% 1,017,940
08/24/08 28.48 +1.24% 2,123,832
07/24/07 28.13 +0.93% 1,560,800

Delayed Quote Xetra, May 13, 2024 at 02:51 pm IST

More quotes
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.67 EUR
Average target price
36.28 EUR
Spread / Average Target
+26.55%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW